SCHEMBL20157599

SCHEMBL20157599

COc1ccc(-c2cn(C)c(=O)cc2CNC(=O)OC(C)(C)C)c(C(=O)c2ccc(C)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.38
TP53 P04637 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
POLB P06746 1/20 0.37
BLM P54132 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BRD4 O60885 6/20 0.37
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
KCNA5 P22460 1/20 0.36
GFER P55789 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RAF1 P04049 1/20 0.36
BRAF P15056 1/20 0.36
PTGS2 P35354 1/20 0.36
DYRK1A Q13627 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157320 0.92 EPHX2 (0.41) MAPTTP53SMN1; SMN2HTTNPSR1
SCHEMBL20157374 0.85 EPHX2 (0.41) MAPTTP53SMN1; SMN2HTTNPSR1
SCHEMBL20158068 0.82 CREBBP (0.34) MAPTTP53ALDH1A1KCNA5RAF1
SCHEMBL20157810 0.80 BRD4 (0.46) SMN1; SMN2BRD4ALDH1A1LMNAKCNA5
SCHEMBL20157348 0.79 HDAC10 (0.35) TP53SMN1; SMN2HTTNPSR1BRD4
SCHEMBL20157896 0.77 BRD4 (0.35) MAPTBRD4KCNA5RAF1BRAF
SCHEMBL21352057 0.76 BRD4 (0.34) SMN1; SMN2BRD4ALDH1A1KCNA5PTGS2
SCHEMBL21362121 0.75 BRD4 (0.34) BRD4RAF1BRAF
SCHEMBL21362034 0.75 RAF1 (0.38) BRD4KCNA5RAF1BRAF
SCHEMBL20157758 0.75 RAF1 (0.40) BRD4RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed